Abstract
Dehydroepiandrosterone (DHEA), one of the major steroid hormones, and its ester have recently received attention with regard to aging and age-related diseases like Alzheimer and others. DHEA is synthesized de novo in the brain and its substantial fall with age has been shown to be associated with neuronal vulnerability to neurotoxicity processes. Thus, DHEA is considered to be a neuroactive pharmacological substance with potential antiaging properties. A prominent feature that accompanies aging is an increase in monoamine oxidase (MAO). Increased MAO activity with correlated increase in lipid peroxidation in the aging rat brain supports the hypothesis that catecholamine oxidation is an important source of oxidative stress. The progressive accumulation of lipofuscin in neuronal cells is one of the most characteristic age related changes, an increase in body weight was also observed at 24 months. The objective of this study was to observe the changes in monoamine oxidase activity, lipid peroxidation levels and lipofuscin accumulation occurring in aging rat brain regions, and to see whether these changes are restored to normal levels after exogenous administration of DHEA (30 mg/kg/day for 1 month). The results obtained in the present work revealed that normal aging was associated with significant increases in the activity of monoamine oxidase, lipid peroxidation levels and lipofuscin accumulation in brain regions of 4, 14 and 24 months age group male rats. The present study showed that DHEA treatment significantly decreased monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in brain regions of aging rats, the increased body weight at 24 months also decreased more than the age matched controls. It can therefore be suggested that DHEA’s beneficial effects seemed to arise from its antioxidant, antiobesity, antilipofuscin, antilipidperoxidative and thereby anti-aging actions. The results of this study will be useful for pharmacological modification of the aging process and development of new drugs for age related disorders.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- CNS:
-
Central nervous system
- DHEA:
-
Dehydroepiandrosterone
- DHEAS:
-
Dehydroepiandrosterone-sulphate
- DMSO:
-
Dimethylsulphoxide
- GABA:
-
Gamma-aminobutyric acid
- MAO:
-
Monoamine oxidase
- MDA:
-
Malondialdehyde
- NMDA:
-
N-methyl-d-aspartate
- PD:
-
Parkinson’s disease
- ROS:
-
Reactive oxygen species
- TBARS:
-
Thiobarbituric acid reactive substance
References
Abrass IB (1990) The biology and physiology of aging. West J Med 153:641–645
Alper G, Girgin FK, Ozgonul M, Mentes G, Ersoz B (1999) MAO inhibitors and oxidant stress in aging brain tissue. Eur Neuropsychopharmacol 9:247–252
Bala K, Tripathy BC, Sharma D (2006) Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7:81–90
Baulieu EE, Robel P (1996) Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol 150:221–239
Benedetti MS, Dostert P (1989) Monoamine oxidase, brain ageing and degenerative diseases. Biochem Pharmacol 38:555–561
Berdanier CD, Parente JA Jr, McIntosh MK (1993) Is dehydroepiandrosterone an antiobesity agent? FASEB 7:414–419
Bergeron R, de Montigny C, Debonnel G (1996) Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16:1193–1202
Boccuzzi G, Aragno M, Seccia M, Brignardello E, Tamagno E, Albano E, Danni O, Bellomo G (1997) Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic Biol Med 22:1289–1294
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Cardounel A, Regelson W, Kalimi M (1999) Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 222:145–149
Cardozo-Pelaez F, Brooks PJ, Stedeford T, Song S, Sanchez-Ramos J (2000) DNA damage, repair, and antioxidant systems in brain regions: a correlative study. Free Radic Biol Med 28:779–785
Catravas GN, Takenaga J, McHale CG (1977) Effect of chronic administration of morphine on monoamine oxidase activity in discrete regions of the brain of rats. Biochem Pharmacol 26:211–214
Celec P, Starka L (2003) Dehydroepiandrostreone – is the fountain of youth drying out? Physiol Res 52:397–407
Cleary MP (1991) The antiobesity effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med 196:8–16
Compagnone NA, Mellon SH (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21:1–56
Drach LM, Bohl J, Goebel HH (1994) The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer’s disease. Dementia 5:234–239
Flood JF, Smith GE, Roberts E (1988) Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447:269–278
Fosslien E (2001) Mitochondrial medicine–molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31:25–67
Fowler CJ, Tipton KF (1984) On the substrate specificities of the two forms of monoamine oxidase. J Pharm Pharmacol 36:111–115
Garcia de Yebenes E, Hong M, Pelletier G (1995) Effects of dehydroepiandrosterone (DHEA) on pituitary prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat. J Neuroendocrinol 7:589–595
Genet S, Kale RK, Baquer NZ (2002) Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonella foenum graecum). Mol Cell Biochem 236:7–12
Hagihara M, Nishigaki I, Maseki M, Yagi K (1984) Age-dependent changes in lipid peroxide levels in the lipoprotein fractions of human serum. J Gerontol 39:269–272
Harman D (1993) Free radical involvment in aging: pathophysiology and therapeutic implications. Drugs Aging 3: 60–80
Hauptmann N, Grimsby J, Shih JC, Cadenas E (1996) The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch Biochem Biophys 335: 295–304
Jahng JW, Houpt TA, Wessel TC, Chen K, Shih JC, Joh TH (1997) Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 25:30–36
Kaur J, Sharma D, Singh R (2001) Acetyl-L-carnitine enhances Na (+), K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci Lett 301:1–4
Kaur J, Singh S, Sharma D, Singh R (2003) Neurostimulatory and antioxidative effects of l-deprenyl in aged rat brain regions. Biogerontology 4:105–111
Kazihnitková H, Tejkalová H, Benesová O, Bicíková M, Hill M, Hampl R (2004) Simultaneous determination of dehydroepiandrosterone, its 7-hydroxylated metabolites, and their sulfates in rat brain tissues. Steroids 69:667–674
Khorram O, Vu L, Yen SS (1997) Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci 52:1–7
Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852–1857
Knoll J (1993) The pharmacological basis of the beneficial effects of (−) deprenyl (selegiline) in Parkinson’s and Alzheimer’s diseases. J Neural Transm Suppl 40:69–91
Labrie F, Diamond P, Cusan L, Gomez JL, Candas B (1997) Effect of 12 month dehdroepiendrosterone replacement therapy on bone, vagina and endometricum in post-menopausal women. J clin Endrocrinol metab 82:3498–3505
Lhullier FL, Riera NG, Nicolaidis R, Junqueira D, Dahm KC, Cipriani F, Brusque AM, Souza DO (2004) Effect of DHEA glutamate release from synaptosomes of rats at different ages. Neurochem Res 29:335–339
Liu J, Wang X, Shigenaga MK, Yeo HC, Mori A, Ames BN (1996) Immobilization stress causes oxidative damage to lipid, protein and DNA in the brain of rats. FASEB J 10:1532–1538
Lucas JA, Ahmed SA, Casey LM, Mc Donald PC (1985) Prevention autoantibody formation and prolonged survival in New-Zealand Black/New Zealand White F1 mice fed dehydroepiandrosterone. J Clin Invest 75:2091–2093
Marklund SL, Westman NG, Lundgren E, Roos G (1982) Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 42:1955–1961
Marx CE, Jarskog LF, Lauder JM, Gilmore JH, Lieberman JA, Morrow AL (2000) Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia. Brain Res 871:104–112
Mayanil CS, Kazmi SM, Baquer NZ (1982) Changes in monoamine oxidase activity in rat brain during alloxan diabetes. J Neurochem 38:179–183
Miyazawa T, Suzuki T, Fujimoto K (1993) Age-dependent accumulation of phosphatidylcholine hydroperoxide in the brain and liver of the rat. Lipids 28:789–793
Moorthy K, Yadav UC, Siddiqui MR, Mantha AK, Basir SF, Sharma D, Cowsik SM, Baquer NZ (2005) Effect of hormone replacement therapy in normalizing age related neuronal markers in different age groups of naturally menopausal rats. Biogerontology 6:345–356
Noda Y, McGeer PL, McGeer EG (1982) Lipid peroxides in brain during aging and vitamin E deficiency: possible relations to changes in neurotransmitter indices. Neurobiol Aging 3:173–178
Oreland L, Gottfries CG (1986) Brain and brain monoamine oxidase in aging and in dementia of Alzheimer’s type. Prog Neuropsychopharmacol Biol Psychiatry 10:533–540
Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metabol 59:551–555
Racchi M, Balduzzi C, Corsini E (2003) Dehdroepiendrosterone (DHEA) and the aging brain: flipping a coin in the ‘‘fountain of youth’’. CNS Drug Rev 9:21–40
Reiter EO, Fuldauer VG, Root AW (1977) Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. J Pediatr 90:766–770
Riga S, Riga D (1974) Effects of centrophenoxine on the lipofuscin pigments in the nervous system of old rats. Brain Res 72:265–275
Richardson JS, Subbarao KV, Ang LC (1992) On the possible role of iron-induced free radical peroxidation in neural degeneration in Alzheimer’s disease. Ann NY Acad Sci 648:326–327
Rodriguez MMA, Ruiz TA (1992) Homeostasis between lipid peroxidation and antioxidant enzymes activities in health human aging. Mech Ageing Dev 66:213–222
Saura J, Richards JG, Mahy N (1994) Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging 15:399–408
Schuessel K, Frey C, Jourdan C, Keil U, Weber CC, Muller-Spahn F, Muller WE, Eckert A (2006) Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic Biol Med 40:850–862
Sharma D, Maurya AK, Singh R (1993) Age-related decline in multiple unit action potentials of CA3 region of rat hippocampus: correlation with lipid peroxidation and lipofuscin concentration and the effect of centrophenoxine. Neurobiol Aging 14:319–330
Sinet PM, Heikkila RE, Cohen G (1980) Hydrogen peroxide production by rat brain in vivo. J Neurochem 34:1421–1428
Sinha N, Baquer NZ, Sharma D (2005) Anti-lipidperoxidative role of exogenous dehydroepiandrosterone (DHEA) administration in normal ageing rat brain. Indian J Exp Biol 43:420–424
Sinha N, Taha A, Baquer NZ, Sharma D (2008) Exogenous administration of Dehydroepiendrosterone attenuates loss of superoxide dismutase activity in the brain of old rats. Indian J Biochem Biophys 45:57–60
Sohal RS, Brunk UT (1989) Lipofuscin as an indicator of oxidative stress and aging. Adv Exp Med Biol 266:17–26
Terman A, Brunk UT (2004) Aging as a catabolic malfunction. Int J Biochem Cell Biol 36:2365–2375
Vedder H, Anthes N, Stumm G, Wurz C, Behl C, Krieg JC (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 72:2531–2538
Weaver CE, Jr Marek P, Park-Chung M, Tam SW, Farb DH (1997) Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94:10450–10454
Wen S, Dong K, Onolfo JP, Vincens M (2001) Treatment with Dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex. Eur J Pharmacol 430:373–374
Wolf OT, Kirschbaum C (1999) Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effect on cognition and emotion in animals and human. Brain Res Rev 30:264–288
Yen TT, Allen JA, Pearson DV, Action JM, Greemberg M M (1977) Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids 12:409–413
Acknowledgements
The authors Pardeep Kumar, Dr. Asia Taha and Prof. N.Z. Baquer are grateful to the financial support from Council of Scientific and Industrial Research in the form of junior and senior research fellowships from Indian Council of Medical Research and emeritus fellowship from University Grants Commission, New Delhi, India respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s10522-008-9148-4
Rights and permissions
About this article
Cite this article
Kumar, P., Taha, A., Sharma, D. et al. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions. Biogerontology 9, 235–246 (2008). https://doi.org/10.1007/s10522-008-9133-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-008-9133-y